Tag: CH0027148649

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsCH0027148649

Texas Southern University Expands Elite Flight Training Fleet with New Twin-Engine Aircraft

Duke Energy offers tips to save energy and money as temperatures rise in the Carolinas

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Badger Meter, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BMI

Tag: CH0027148649

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us